Basit öğe kaydını göster

dc.contributor.authorGul, Umit
dc.date.accessioned2019-11-26T08:53:03Z
dc.date.available2019-11-26T08:53:03Z
dc.date.issued2015
dc.identifier.issn2147-2270
dc.identifier.uri10.4274/uob.419
dc.identifier.urihttp://hdl.handle.net/11727/4244
dc.description.abstractRetroperitoneal masses are extremely rare. They may be primary malignant, benign or metastatic. The majority of them are malignant. Possible causes that may reveal the etiology of these masses have not been clarified yet. However some predisposing factors have been identified. These masses are classified according to their histological types. Clinical signs are presence of abdominal mass and abdominal pain. A multidisciplinary approach for diagnosis and treatment in high-volume referral centers is ideal. Retroperitoneal masses are treated surgically as much as possible. It is important to achieve negative surgical margins. Optimal treatment approaches have not been standardized as of today. Anthracycline chemotherapy which may be combined with radiotherapy forms the basis of therapy. Developments related to targeted therapies are particularly promising.en_US
dc.language.isoturen_US
dc.relation.isversionof10.4274/uob.419en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectRetroperitoneal neoplasmsen_US
dc.subjectretroperitoneal liposarcomaen_US
dc.subjectdiagnosisen_US
dc.subjecttherapyen_US
dc.titleThe Diagnosis and Treatment of Retroperitoneal Massen_US
dc.typereviewen_US
dc.relation.journalUROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGYen_US
dc.identifier.volume14en_US
dc.identifier.issue3en_US
dc.identifier.startpage196en_US
dc.identifier.endpage202en_US
dc.identifier.wos000219416700007en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster